Infections of the central nervous system (CNS) affect 3-4% of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). 1 Fungal, viral and parasitic organisms may be involved and these infections carry a high mortality. Aspergillus was thought to be the most common pathogen, while toxoplasma was considered rare. 2 However, a report from Germany showed that toxoplasmosis was responsible for 75% of their cases. 3 We encountered a case of cerebral toxoplasmosis where the presenting feature was isolated hyponatremia.
An 8-year-old Argentinean boy with ALL in CR2 received a one-antigen mismatched HSCT from his brother. He developed grade II GVHD on day þ 36 and was treated with systemic steroids, and continuing cyclosporine. On day þ 76, hyponatremia was noted, which became progressively more severe (Figure 1 ). The patient, however, remained asymptomatic and continued to be followed in the clinic twice a week. On day þ 89, the patient was readmitted with a 1-day history of fever, mild occipital headache, vomiting, and lethargy. No focal neurologic signs were detected on physical examination. The patient was suspected to have cerebral salt wasting (CSW) due to the following findings: slight decrease in body weight, increase in urine output, and normal uric acid level. The serum osmolality was 247 mOsm/kg and the urine osmolality was 234 mOsm/kg. Two boluses of hypertonic saline were administered, with only transient improvement of serum sodium level. The patient was started on antimicrobials to cover bacterial, fungal, and CMV infection. By the 4th day of admission, the patient became stuporous and hemiparetic. An MRI of the brain revealed ring-like lesions in the basal ganglia and thalamic regions, with surrounding edema. Bilateral retinal infiltrates were present on ophthalmologic examination. Pyrimethamine, sulfadiazine, and clindamycin were added. A brain biopsy showed trophozoites compatible with toxoplasmosis. Serum sodium level improved and the patient's neurologic and general status recovered quickly. He was discharged 2 weeks after admission. The patient was seropositive for toxoplasmosis prior to HSCT and he was on dapsone prophylaxis when toxoplasmosis was diagnosed.
The prevalence of diagnosing toxoplasmosis after HSCT is influenced by the endemicity of the region, autopsy rate, and diagnostic techniques. 2, 3 Nearly all cases have occurred in patients who are seropositive prior to conditioning. Other high-risk factors include GVHD and immunosuppressive therapy, as well as recipients of T-cell-depleted grafts. 4 Most infections occurred between the 2nd and 6th month after HSCT, and many cases are disseminated at presentation. The CNS is the organ most often affected, but involvement of the lungs and myocardium are also found. The prognosis is poor due to the delay in diagnosis. Overall mortality reaches 80%, and many cases are discovered only at post mortem. However, for patients who have lived to receive more than 3 days of antitoxoplasma therapy, 48% showed a complete response and another 13% improved. 3 This indicates the critical significance of early detection and institution of appropriate therapy.
Unfortunately, the diagnosis of toxoplasmosis after HSCT is difficult. The presenting symptoms such as fever, seizure, headache, and cognitive disturbances are nonspecific. MRI is more specific than computerized tomography, but inflammatory reactions such as edema and enhancement are less prominent probably due to the post transplant immunodeficient state. 5 Serologic testing has no significant role in the diagnosis. Polymerase chain reaction of body fluids may provide an early diagnosis, but the lack of standardization of the test hampers its value. 6 While trimethoprim-sulfamethoxazole is the best proven prophylaxis for toxoplasmosis, it does not always prevent protozoal reactivation. 7 Delaying antitoxoplasma therapy until the test results are available may negatively affect the course of the infection. Hyponatremia was seen in 10.3% of children with acute CNS disease. It was most commonly associated with infection by mycobacteria and viral organisms. 8 The manifestations of hyponatremia are nonspecific and may include lethargy, seizures, and personality changes. Some of these symptoms are also seen in patients with CNS infection. Hyponatremia may be caused by two different mechanisms: (1) the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), and CSW. 9 SIADH results in a positive fluid balance because of renal salt retention. Dilutional hyponatremia and hypouricemia occur. CSW is due to primary natriuresis, leading to volume depletion and weight loss. Bussmann et al 
